SCHEMBL7676003

SCHEMBL7676003

COc1ccc(NC(=O)c2c[nH]c3c(c2=O)CCCCC3)cc1

nearest known ligand 0.62

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 6/20 0.62
SMN1; SMN2 Q16637 6/20 0.57
TP53 P04637 5/20 0.57
NPC1 O15118 5/20 0.55
RAB9A P51151 5/20 0.55
NFKB1 P19838 1/20 0.55
CASP3 P42574 1/20 0.55
NFKB2 Q00653 1/20 0.55
RELA Q04206 1/20 0.55
SENP7 Q9BQF6 1/20 0.55
RECQL P46063 2/20 0.50
GAA P10253 1/20 0.50
TSHR P16473 1/20 0.49
LMNA P02545 2/20 0.46
ALDH1A1 P00352 3/20 0.46
POLB P06746 1/20 0.46
NR4A1 P22736 1/20 0.46
TDP1 Q9NUW8 1/20 0.46
MEN1 O00255 1/20 0.45
KMT2A Q03164 1/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7446323 0.99 MAPT (0.64) MAPTSMN1; SMN2TP53NPC1RAB9A
SCHEMBL7680828 0.96 MAPT (0.61) MAPTSMN1; SMN2TP53NPC1RAB9A
SCHEMBL7446245 0.85 TP53 (0.68) MAPTSMN1; SMN2TP53NPC1RAB9A
SCHEMBL6162159 0.84 ADORA2A (0.57) MAPTTP53RAB9ATSHRALDH1A1
SCHEMBL7679353 0.83 TP53 (0.66) MAPTSMN1; SMN2TP53NPC1RAB9A
SCHEMBL7446235 0.83 TP53 (0.52) MAPTSMN1; SMN2TP53NPC1RAB9A
SCHEMBL6164599 0.83 ADORA2A (0.58) MAPTRAB9ATSHRALDH1A1POLB
SCHEMBL7454498 0.83 CFTR (0.56) MAPTSMN1; SMN2TP53NPC1RAB9A
SCHEMBL7398647 0.82 MAPT (0.53) MAPTSMN1; SMN2TP53NPC1RAB9A
SCHEMBL6162143 0.82 ADORA2A (0.57) MAPTRAB9ATSHRALDH1A1POLB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6448259-B1 CYCLOALKYL-4-OXONICOTINIC CARBOXAMIDES; AGONISTS, ANTAGONISTS OR INVERSE AGONISTS FOR GAMMA AMINOBUTYRIC ACID BINDING SITE, THE BENZODIAZEPINE RECEPTOR; ANXIETY, SLEEP AND SEIZURE DISORDERS SEDATIVE, ANXIOLYTIC AND ANTICONVULSANT ACTIVITY NEUROGEN CORPORATION 2002-09-10 US claimed
US-6448259-B1 CYCLOALKYL-4-OXONICOTINIC CARBOXAMIDES; AGONISTS, ANTAGONISTS OR INVERSE AGONISTS FOR GAMMA AMINOBUTYRIC ACID BINDING SITE, THE BENZODIAZEPINE RECEPTOR; ANXIETY, SLEEP AND SEIZURE DISORDERS SEDATIVE, ANXIOLYTIC AND ANTICONVULSANT ACTIVITY NEUROGEN CORPORATION 2002-09-10 US disclosed
US-6194427-B1 BRAIN DISORDERS; PSYCHOLOGICAL DISORDERS; SLEEP DISORDERS; ANTICONVULSANTS NEUROGEN CORPORATION 2001-02-27 US disclosed